Søg i kliniske forsøg efter: HLA-A*2402
I alt 472137 resultater
-
Shiga UniversityTokyo UniversityAfsluttet
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUkendtIkke småcellet lungekræftJapan
-
Shiga UniversityTokyo UniversityAfsluttet
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetKolorektal cancer | Endetarmskræft | TyktarmskræftJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetIkke småcellet lungekræftJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetIkke-småcellet lungekræftJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetIkke-småcellet lungekræftJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
BrightPath BiotherapeuticsAfsluttet
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUkendtKræft i bugspytkirtlen | Bugspytkirtel neoplasmerJapan
-
Kinki UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Kinki UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
University of CincinnatiMillennium Pharmaceuticals, Inc.Afsluttet
-
Northwestern UniversityAfsluttetTransplantationssensibilisering | Panelreaktivt antistof | Sensibilisering over for HLA-antigenerForenede Stater
-
Jonsson Comprehensive Cancer CenterCalifornia Institute for Regenerative Medicine (CIRM)AfsluttetSarkom | Ikke-operable ondartet neoplasma | Lokalt avanceret malignt neoplasma | HLA-A*0201 Positive celler til stede | NY-ESO-1 positivForenede Stater
-
University Hospital, BrestAfsluttetNæste generations sekvensering til HLA-tastningFrankrig
-
Cue BiopharmaRekrutteringMavekræft | Kolorektal cancer | Kræft i bugspytkirtlen | LivmoderhalskræftForenede Stater
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttetKolorektal cancer | Endetarmskræft | TyktarmskræftJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Shiga UniversityTokyo UniversityAfsluttet
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetTilbagevendende ovariekarcinom | HLA-A*0201 Positive celler til stede | COL6A3 Positiv | PRAME PositivForenede Stater
-
Sechenov UniversityPirogov Russian National Research Medical UniversityRekrutteringBulløs pemfigoid | Stevens-Johnsons syndrom | Toksiske epidermale nekrolyser | PemphigusDen Russiske Føderation
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUkendtIkke småcellet lungekræftJapan
-
Universidad Europea de MadridRekrutteringHyperglykæmi | Hypoglykæmi | Diabetes | Kritisk pleje | Kritisk syge patienterSpanien
-
University of California, San FranciscoParker Institute for Cancer Immunotherapy; The V Foundation; Alliance for...RekrutteringDiffus Midline Glioma, H3 K27M-MutantForenede Stater
-
Life Technologies CorporationAfsluttetHumane leukocytantigener (HLA)
-
National Institute on Alcohol Abuse and Alcoholism...AfsluttetFedme | Sunde emner | Vægtøgning | KvinderForenede Stater
-
State-Financed Health Facility "Samara Regional...INBIO, LLCRekrutteringCerebral PareseDen Russiske Føderation
-
Anhui Provincial HospitalIkke rekrutterer endnuHøje titre af anti-HLA-antistof (MFI ≥5000)Kina
-
Immunocore LtdRekrutteringHepatitis B, kroniskHong Kong, Korea, Republikken, Taiwan, Danmark, Forenede Stater, Australien, Rumænien, Det Forenede Kongerige, Spanien
-
DatabeanOctapharmaAfsluttetNyretransplantationsmodtagere med anti-HLA-antistofferForenede Stater
-
National Cancer Institute (NCI)AfsluttetProstata neoplasmer | Prostata specifikke antigenerForenede Stater
-
Hopital du Sacre-Coeur de MontrealGlaxoSmithKlineAfsluttet
-
Corporacion Parc TauliAfsluttetCøliakipatienter, der følger anbefalingerne fra ESPGHAN | HLA-DQ2-typning Inkluderer HLA-DR7-DQ2-haplotyperSpanien
-
Central Hospital, Nancy, FranceAktiv, ikke rekrutterendeNyretransplantation | Dialyse | Immunsuppressive midler | HLA-sensibiliseringFrankrig
-
Second Xiangya Hospital of Central South UniversityRekruttering
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAfsluttet
-
Nantes University HospitalInstitut de Recherche en Santé RespiratoireRekrutteringGraviditet | Afvisning af transplantat | LungetransplantationFrankrig
-
Ludwig Institute for Cancer ResearchAfsluttet
-
Hannover Medical SchoolRekrutteringLungetransplantation | Donorspecifikke anti-humant leukocytantigen (HLA) antistofferTyskland
-
Al Baraka Fertility HospitalIbn Sina Hospital; Sadat City UniversityAfsluttetGenetiske sygdomme, medfødte | Mutation | Kromosomabnormiteter
-
Assistance Publique - Hôpitaux de ParisEtablissement Français du Sang (Nouvelle Aquitaine)RekrutteringBloddonorer | Anti-HLA antistofFrankrig
-
Fondazione Policlinico Universitario Agostino Gemelli...Afsluttet
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)AfsluttetAkut myeloid leukæmi | EBV-positive neoplastiske celler til stede | HLA-A*0201 Positive celler til stede | Sprængninger under 5 procent af knoglemarvskerneholdige celler | Forhøjet WT1Forenede Stater
-
DynPort Vaccine Company LLC, A GDIT CompanyAfsluttetREKOMBINANT BOTULINUM VACCINE A/BForenede Stater
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRekrutteringVirusinfektionForenede Stater
-
Piera BoschettoAfsluttet